Scott H. Stansfield

854 total citations
14 papers, 674 citations indexed

About

Scott H. Stansfield is a scholar working on Molecular Biology, Microbiology and Oncology. According to data from OpenAlex, Scott H. Stansfield has authored 14 papers receiving a total of 674 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 4 papers in Microbiology and 3 papers in Oncology. Recurrent topics in Scott H. Stansfield's work include Viral Infectious Diseases and Gene Expression in Insects (5 papers), Reproductive tract infections research (4 papers) and Monoclonal and Polyclonal Antibodies Research (3 papers). Scott H. Stansfield is often cited by papers focused on Viral Infectious Diseases and Gene Expression in Insects (5 papers), Reproductive tract infections research (4 papers) and Monoclonal and Polyclonal Antibodies Research (3 papers). Scott H. Stansfield collaborates with scholars based in Australia, United Kingdom and New Zealand. Scott H. Stansfield's co-authors include John Birch, Andrew J. Racher, David C. James, Diane M. Dinnis, Stefan Schlatter, C. Mark Smales, Judith A. Clements, Johannes Reichert, Leslie Burke and Verena M.C. Quent and has published in prestigious journals such as PLoS ONE, Biomaterials and Experimental Cell Research.

In The Last Decade

Scott H. Stansfield

14 papers receiving 654 citations

Peers

Countries citing papers authored by Scott H. Stansfield

Since Specialization

Citations

This map shows the geographic impact of Scott H. Stansfield's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Scott H. Stansfield with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Scott H. Stansfield more than expected).

Fields of papers citing papers by Scott H. Stansfield

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Scott H. Stansfield. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Scott H. Stansfield. The network helps show where Scott H. Stansfield may publish in the future.

Co-authorship network of co-authors of Scott H. Stansfield

This figure shows the co-authorship network connecting the top 25 collaborators of Scott H. Stansfield. A scholar is included among the top collaborators of Scott H. Stansfield based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Scott H. Stansfield. Scott H. Stansfield is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

#	Work	Indexed citations
1	Impact of the COVID‐19 pandemic and multiple community lockdowns on total live birth rates and preterm births in Melbourne, Australia 2022 ·Australian and New Zealand Journal of Obstetrics and Gynaecology ·Scott H. Stansfield, (unknown), Ben W. Mol, Daniel L. Rolnik, Anil K. Malhotra	5
2	Sero-epidemiological assessment of Chlamydia trachomatis infection and sub-fertility in Samoan women 2016 ·BMC Infectious Diseases ·Shruti Menon, Scott H. Stansfield, M. Walsh, (unknown), (unknown), Antoinette Righarts, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Peter Timms, Philip C. Hill, Wilhelmina M. Huston	19
3	Prostate Cancer-Associated Kallikrein-Related Peptidase 4 Activates Matrix Metalloproteinase-1 and Thrombospondin-1 2016 ·Journal of Proteome Research ·(unknown), Scott H. Stansfield, Carson Stephens, Daniela Loessner, Judith A. Clements	23
4	Development and evaluation of a multi-antigen peptide ELISA for the diagnosis of Chlamydia trachomatis-related infertility in women 2016 ·Journal of Medical Microbiology ·Shruti Menon, Scott H. Stansfield, (unknown), Jane S. Hocking, Peter Timms, Luk Rombauts, John Allan, Wilhelmina M. Huston	8
5	Murine, but not human, ephrin-B2 can be efficiently cleaved by the serine protease kallikrein-4: Implications for xenograft models of human prostate cancer 2015 ·Experimental Cell Research ·Jessica Lisle, (unknown), (unknown), Scott H. Stansfield, Judith A. Clements, Adrian C. Herington, (unknown)	8
6	Proof of concept: A bioinformatic and serological screening method for identifying new peptide antigens for Chlamydia trachomatis related sequelae in women 2013 ·PubMed ·Scott H. Stansfield, Pooja Patel, Joseph Debattista, Charles W. Armitage, Kelly Cunningham, Peter Timms, John Allan, Aruna Mittal, Wilhelmina M. Huston	11
7	The Active Site Residue V266 of Chlamydial HtrA Is Critical for Substrate Binding during both in vitro and in vivo Conditions 2012 ·Microbial Physiology ·(unknown), Joel D. A. Tyndall, Scott H. Stansfield, Peter Timms, Wilhelmina M. Huston	13
8	Unique Residues Involved in Activation of the Multitasking Protease/Chaperone HtrA from Chlamydia trachomatis 2011 ·PLoS ONE ·Wilhelmina M. Huston, Joel D. A. Tyndall, William B. Lott, Scott H. Stansfield, Peter Timms	24
9	Mineralized human primary osteoblast matrices as a model system to analyse interactions of prostate cancer cells with the bone microenvironment 2010 ·Biomaterials ·Johannes Reichert, Verena M.C. Quent, Leslie Burke, Scott H. Stansfield, Judith A. Clements, Dietmar W. Hutmacher	100
10	Dynamic analysis of GS‐NS0 cells producing a recombinant monoclonal antibody during fed‐batch culture 2006 ·Biotechnology and Bioengineering ·Scott H. Stansfield, (unknown), Diane M. Dinnis, Andrew J. Racher, John Birch, David C. James	35
11	Functional proteomic analysis of GS‐NS0 murine myeloma cell lines with varying recombinant monoclonal antibody production rate 2006 ·Biotechnology and Bioengineering ·Diane M. Dinnis, Scott H. Stansfield, Stefan Schlatter, C. Mark Smales, (unknown), John Birch, Andrew J. Racher, (unknown), Lars K. Nielsen, David C. James	112
12	On the Optimal Ratio of Heavy to Light Chain Genes for Efficient Recombinant Antibody Production by CHO Cells 2005 ·Biotechnology Progress ·Stefan Schlatter, Scott H. Stansfield, Diane M. Dinnis, Andrew J. Racher, John Birch, David C. James	181
13	Proteomic analysis of enriched microsomal fractions from GS‐NS0 murine myeloma cells with varying secreted recombinant monoclonal antibody productivities 2005 ·PROTEOMICS ·(unknown), Andrew J. Racher, John Birch, Scott H. Stansfield, David C. James, C. Mark Smales	38
14	Comparative proteomic analysis of GS‐NS0 murine myeloma cell lines with varying recombinant monoclonal antibody production rate 2004 ·Biotechnology and Bioengineering ·C. Mark Smales, Diane M. Dinnis, Scott H. Stansfield, (unknown), (unknown), John Birch, Andrew J. Racher, (unknown), David C. James	97

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact